PCOD vs PCOS vs PMOS: A Pharmacist Explains the Difference
Written by Josef Saleh, MPharm, Licensed Pharmacist
If you have been told you have PCOD, or PCOS, or have just heard that PCOS is now called PMOS, you are probably wondering what any of these terms actually mean and whether the difference matters for your health. It does, and the confusion between them is something I help patients untangle regularly at the pharmacy counter.
The simplest way I explain it to patients is this. PCOD is a picture. PMOS is a patient. Understanding that distinction changes everything about how you think about your diagnosis, your symptoms, and whether you actually need treatment.
| PCOD | PMOS (formerly PCOS) | |
| What it is | Ovarian morphology finding | Full metabolic syndrome |
| Diagnosed by | Ultrasound alone | 2 of 3 clinical criteria |
| Hormonal involvement | Not necessarily | Usually yes |
| Metabolic risk | Low | Significant |
| Needs supplements | Usually not | Often yes |
| Affects fertility | Sometimes | More commonly |
What is the difference between PCOD and PCOS?
PCOD, which stands for polycystic ovarian disease or polycystic ovarian disorder, is an older and less precise term. It usually refers to the presence of multiple small follicles visible on an ultrasound scan. It does not automatically mean you have a hormonal or metabolic condition. A woman can have polycystic-appearing ovaries with completely regular periods, normal hormone levels, and no insulin resistance. That is simply her ovarian morphology.
PCOS, now officially renamed PMOS, is a different category entirely. It is diagnosed when a patient meets at least two of three criteria: irregular ovulation, elevated androgens either on blood tests or clinical signs like acne and excess hair, and polycystic ovaries on ultrasound1. It is a syndrome, meaning a collection of signs and symptoms that travel together, driven in large part by insulin resistance and metabolic dysfunction.
The key clinical distinction is this. PCOD is a finding. PMOS is a diagnosis. You can have a polycystic-appearing ovary without any syndrome. But if you have PMOS, you almost always have metabolic involvement that needs attention beyond the ovaries.
How does PCOD fit into the PMOS era?
The rename from PCOS to PMOS actually clarifies the PCOD confusion beautifully. PCOD remains a morphological description. It says your ovaries look a certain way. It does not speak to metabolism, hormones, or cardiovascular risk. PMOS tells the full story. It says there is a metabolic root driving irregular cycles, high androgens, and often the ovarian appearance seen on ultrasound.
PCOD is not a milder form of PMOS. It is a different category altogether. Think of it like this. Having dandruff does not mean you have psoriasis, even though some flakes look similar on the surface. PCOD is a feature that may be part of PMOS, but it is not the whole condition and does not carry the same clinical weight3.
In the new picture, if a patient has polycystic ovaries on ultrasound but regular periods, normal androgens, and no insulin resistance, she does not have PMOS. She has PCOD morphology, which is clinically much less concerning. The rename helps us stop labelling every polycystic ovary as a syndrome when it is not one.
Do PCOD and PMOS need different supplements?
Yes, and this is where a pharmacist can really help. The supplements that work for PMOS target the metabolic dysfunction at the root of the condition. If that metabolic dysfunction is not present, those same supplements have a much weaker rationale.
For isolated PCOD with no metabolic features, regular periods and normal androgens, I would not routinely recommend inositol or berberine. The evidence for both is strongest in insulin-resistant states. Without insulin resistance, the clinical justification is weak. A good general multivitamin, zinc if levels are low, and vitamin D if deficient is usually sufficient.
For PMOS, the approach is meaningfully different. Inositol at the 40:1 myo to d-chiro ratio is first-line in my thinking, alongside berberine if blood sugar control is a priority. Magnesium, zinc, and vitamin D all have a place because they address the metabolic undercurrent. I have covered the full evidence base for these in my guide to PMOS supplements.
The mistake I often see is patients being given inositol or berberine just because an ultrasound said PCOD. That can be unnecessary. Supplements should target the pathology, not just the picture. If you have PCOD without PMOS, you may not need anything beyond a healthy lifestyle and regular monitoring.
The most common diagnosis mix-up I see
The biggest mix-up is when a patient comes in with an ultrasound report that says polycystic ovaries and believes she has the full syndrome. She has often been told she has PCOD and nobody explained what that actually means or whether it requires treatment.
When this happens I always ask three questions. Are your periods regular? Do you have acne, excess hair, or hair thinning? Have you had blood sugar or lipid tests done? If her cycles are regular and she has no signs of elevated androgens, I gently explain that the ultrasound finding alone does not define the condition. She may simply have ovaries that naturally look that way. I have seen countless women relieved to learn they do not have a chronic metabolic syndrome after all.
The opposite also happens. A woman with classic PMOS symptoms — irregular cycles, weight gain, hirsutism — was never properly diagnosed because her doctor did not connect the metabolic dots. With PMOS now emphasising the metabolic side of the condition, I hope diagnosis rates will improve because clinicians will be looking for insulin resistance, not just cysts.
PCOD, PCOS and PMOS in the South Asian context
This is a significant practical issue that does not get enough attention. In India, Pakistan, Bangladesh, and surrounding countries, PCOD is the term ingrained in both the medical community and among patients. It is used almost synonymously with PCOS, even though clinically they should be distinct categories.
With PMOS now replacing PCOS, I have not yet seen official clinical guidance from Indian or South Asian endocrinology societies on unified terminology. What I tell South Asian patients is this. The term you have heard, PCOD, often refers to what we now call PMOS. In practice, if your doctor in India told you that you have PCOD and described irregular periods, hormonal issues, and metabolic risk, they were talking about what we now label PMOS. But technically, PCOD is just the ovarian picture. PMOS is the condition that needs treatment.
This confusion will not disappear overnight. In South Asia, PCOD will likely remain the public-facing term for years while formal guidelines slowly adopt PMOS. For the pharmacist, the most important thing is to look past the label and assess the actual clinical features. Metabolic health, cycle regularity, androgen symptoms. If a patient says she has PCOD, I treat it as probable PMOS until I can clarify further. That way I do not dismiss a metabolic syndrome that needs attention.
What should you do if you have PCOD?
If you have been told you have PCOD, the first step is to understand whether it is truly isolated PCOD or whether it meets the criteria for PMOS. Ask your doctor these questions. Do I have irregular periods or ovulation problems? Do I have elevated androgens on blood tests or clinical signs? Do I have insulin resistance or blood sugar concerns?
If the answer to all three is no, you likely have polycystic ovarian morphology without the full syndrome. This is common, not dangerous, and does not automatically require supplements or treatment. Regular monitoring and a healthy lifestyle are usually sufficient.
If the answer to one or more is yes, you may have PMOS and a more targeted approach makes sense. That means addressing insulin resistance through diet, exercise, and where appropriate, supplements with real clinical evidence behind them2. I have covered both the supplement options and a practical eating plan in dedicated guides.
The bottom line
PCOD and PMOS are not the same thing, even though they are frequently used interchangeably. PCOD is an ultrasound finding. PMOS is a metabolic syndrome with real long-term health implications. Having one does not automatically mean you have the other.
The rename from PCOS to PMOS is a step toward greater clarity. It shifts focus from the ovaries to the underlying metabolic dysfunction that actually drives the condition. For patients, that means better diagnosis. For pharmacists and clinicians, it means more targeted treatment. And for the many women who have been told they have PCOD without a clear explanation of what that means, it is an opportunity to finally get the right answers.
References
1. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19-25.
2. Teede HJ, Misso ML, Costello MF, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. J Clin Endocrinol Metab. 2018;103(9):1236-1259.
3. Teede HJ, Bahri Khomami M, Morman R, et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. Lancet. Published online May 12, 2026. doi:10.1016/S0140-6736(26)00717-8.
This post contains affiliate links. If you purchase through my links I may earn a small commission at no extra cost to you.
Written by Josef Saleh, MPharm, Licensed Pharmacist. This article is for informational purposes only and does not constitute medical advice. Always consult your doctor before making any changes to your treatment or supplement plan.
